Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2012
07/11/2012CN101830935B Solanum cathayanum alkaloid extract and preparation method and application thereof
07/11/2012CN101801342B Methods for producing aripiprazole suspension and freeze-dried formulation
07/11/2012CN101791295B Compound monoammonium glycyrrhizinate S pharmaceutical composition and method for preparing frozen powder injection
07/11/2012CN101780279B Application of Toll-link receptor-3 agonist to preparation of medicines for promoting wound healing
07/11/2012CN101775053B Method for extracting amino acid and nucleic acid from shell, hoofs and horns of animal
07/11/2012CN101773471B Mitoxantrone targeting sustained-release long-circulating nanometer liposome and preparation method
07/11/2012CN101735172B Cinepazide monohydrate, crystal forms and preparation method thereof
07/11/2012CN101701218B Immune regulatory oligodeoxynucleotide for inhibiting differentiation of Th1 and Th17 and application thereof
07/11/2012CN101693037B Application of flavonoid glycoside compounds in preparation of medicines for treating malaria
07/11/2012CN101669938B Nutrient composition for eliminating exercise-induced fatigue
07/11/2012CN101648867B Crystal form of Pravastatin Na, and preparation method and application thereof
07/11/2012CN101646662B Novel prophylactic and/or therapeutic agent for diabetic neuropathy
07/11/2012CN101643493B Peininine bile acid ester, method for preparing same and application thereof
07/11/2012CN101641360B Piperazine derivatives, preparation process and pharmaceutical use thereof
07/11/2012CN101637481B Prescription of gingkgo leaf soft capsule and preparation method thereof
07/11/2012CN101618126B Analgesic antiphlogistic gel and preparation method thereof
07/11/2012CN101596165B Pantoprazole sodium enteric-coated pellet
07/11/2012CN101583597B Sulfonamide derivatives as liver carnitine palmitoyl transferase (L-CPT1)
07/11/2012CN101573448B Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same
07/11/2012CN101570560B Two sterol derivatives, separation and extraction method thereof and application thereof in preventing and treating prostatoplasia diseases
07/11/2012CN101555214B Phenylcyclobutylacylamide derivative as well as optical isomer, preparation method and application thereof
07/11/2012CN101522185B Antidepressant agent
07/11/2012CN101497581B Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
07/11/2012CN101481356B Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
07/11/2012CN101429174B Piperazine derivant with antineoplastic activity
07/11/2012CN101384600B Crystalline forms of (3r,4r)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methol]piperidin-3-ol
07/11/2012CN101353344B Pyrazolyl-substituted heterocycles and their use as phytosanitary products
07/11/2012CN101288641B Coenzyme Q10 water dispersion and preparation method thereof
07/11/2012CN101282978B Macrocylic inhibitors of hepatitis c virus
07/11/2012CN101193907B Novel triterpenic acid derivative and external application agent for skin comprising the same
07/11/2012CN101147803B Anti Toll-like receptor 2 antibody inhibiting tumor metastasis use
07/11/2012CN101139345B Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
07/11/2012CN101077866B Substituted benzoxazoles antifungal compounds and preparation method thereof
07/11/2012CN101056617B In-situ forming implant for animals
07/11/2012CN101054417B Recombinant antibodies related to ganglioside and its application in diagnosing and treating tumor
07/11/2012CN101006065B Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
07/11/2012CA2727477A1 Stable ready to use injectable paracetamol formulation
07/10/2012US8217189 Chromenone potassium channel blockers and uses thereof
07/10/2012US8217182 Process for producing cyclic N-hydroxy imide compounds
07/10/2012US8217178 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-flouro-1-(2-methoxy-ethyl)-4-trifluorom as an inhibitor of mast cell tryptase
07/10/2012US8217177 Fused heterocyclic derivatives and methods of use
07/10/2012US8217171 Antiviral agents
07/10/2012US8217168 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine D3 receptors
07/10/2012US8217164 Use of a lactose-derived C-glycoside compound as an agent for activating and regulating cutaneous immunity
07/10/2012US8217163 Application of highly conserved domain sequences from viral genome as template to design therapeutic slirnas
07/10/2012US8217151 Pasteurisation process for microbial cells and microbial oil
07/10/2012US8217146 Neurotrophic factors and methods of use thereof
07/10/2012US8217137 Fullerene-based amino acids
07/10/2012US8217123 Stabilized polymeric thiol reagents
07/10/2012US8217086 Phenoxy acetic acids as PPAR delta activators
07/10/2012US8217085 Methylsulfonylmethane (MSM) for treatment of drug resistant microorganisms
07/10/2012US8217084 Medicinal products incorporating bound organosulfur groups
07/10/2012US8217083 Mesalamine suppository
07/10/2012US8217080 Anti-infective methods and systems for treating pathogen-induced disordered tissues
07/10/2012US8217079 Method for treating Philadelphia-negative myeloproliferative syndromes
07/10/2012US8217078 Treatment of pain with topical diclofenac
07/10/2012US8217077 HMB uses thereof
07/10/2012US8217076 Method for preparing largazole analogs and uses thereof
07/10/2012US8217075 2-amino-2-phenyl-alkanol derivatives, their preparation and pharmaceutical compositions containing them
07/10/2012US8217073 Pyrrole derivatives as therapeutic compounds
07/10/2012US8217072 Fermentation product of marine actinomyces strains; antiproliferative agents; anticarcinogenic agents; low molecular weight, high pharmaceutical potency, and selectivity for cancer cells
07/10/2012US8217071 Use of inhibitors of the degradation of p27, in particular Argyrin and derivatives thereof, for the treatment of proliferative diseases
07/10/2012US8217070 2-substituted-1H-benzimidazole-4-carboxamides are PARP inhibitors
07/10/2012US8217069 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
07/10/2012US8217068 Compound with anesthetics activity, methods for its production and pharmaceutical compositions comprising the same
07/10/2012US8217067 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine
07/10/2012US8217066 Compounds as lysophosphatidic acid receptor antagonists
07/10/2012US8217065 Organic compounds
07/10/2012US8217064 Tetrasubstituted benzenes
07/10/2012US8217063 Lactam-substituted dicarboxylic acids and use thereof
07/10/2012US8217061 Polymorphs of sorafenib tosylate and sorafenib hemi-tosylate, and processes for preparation thereof
07/10/2012US8217060 Benzimidazole derivatives useful as TRP M8 receptor modulators
07/10/2012US8217058 Substituted piperidino phenyloxazolidinones
07/10/2012US8217057 Polymorphs of a c-MET/HGFR inhibitor
07/10/2012US8217056 Triazolothiadiazole inhibitor of c-Met protein kinase
07/10/2012US8217055 Pyrido-pyrazine derivatives useful as herbicidal compounds
07/10/2012US8217054 Use of polyols to obtain stable polymorphous forms of rifaximin
07/10/2012US8217053 Camptothecin derivatives with antitumor activity
07/10/2012US8217052 Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
07/10/2012US8217051 Spiroindolinone derivatives
07/10/2012US8217050 Adenine derivative as inhibitors of HSP90 for the treatment of cancer
07/10/2012US8217048 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
07/10/2012US8217047 Therapeutic methods and compounds
07/10/2012US8217046 Cinnamoyl-piperazine derivatives and their use as PAR-1 antagonists
07/10/2012US8217045 Organic compounds
07/10/2012US8217044 Spiroindolinone pyrrolidines
07/10/2012US8217043 Compounds and methods for their use
07/10/2012US8217042 Pyridopyrazines and their use as modulators of kinases
07/10/2012US8217041 Indene derivatives, their preparation and use as medicaments
07/10/2012US8217040 Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect
07/10/2012US8217039 Aprepitant polymorph mixtures
07/10/2012US8217038 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
07/10/2012US8217037 Thiazole and thiophene analogues, and their use in treating autoimmune diseases and cancers
07/10/2012US8217036 Triazine compounds as PI3 kinase and mTOR inhibitors
07/10/2012US8217035 Pyrimidine derivatives used as PI-3-kinase inhibitors
07/10/2012US8217034 Chemical compounds
07/10/2012US8217033 Methods and compositions for the delivery of a therapeutic agent
07/10/2012US8217032 Selective estrogen receptor modulators for the treatment of vasomotor symptoms
07/10/2012US8217031 Heteroaryl derivatives
07/10/2012US8217030 Association of a sinus node if current inhibitor and a beta blocker